Cryo-Cell International, Inc. Quarterly report [Sections 13 or 15(d)]

Notes Payable (Tables)

3 Months Ended

Feb. 28, 2026

As of February 28, 2026 and November 30, 2025, the note payable obligation was as follows:


	February 28, 2026			November 30, 2025
Note payable - Susser	$	8,440,835		$	8,481,125
Unamortized debt issuance costs - Susser		(122,209	)		(127,345	)
Net note payable	$	8,318,626		$	8,353,780
Current portion of note payable	$	191,085		$	183,650
Long-term note payable, net of debt issuance costs		8,127,541			8,170,130
Total	$	8,318,626		$	8,353,780

Future principal payments under the note payable obligation are as follows:


Years ending February 28:	Amount
2027	$	191,085
2028		204,785
2029		217,119
2030		231,024
2031		245,829
Thereafter		7,350,993
Less: Unamortized debt issuance costs		(122,209	)
Total	$	8,318,626

Interest expense on the note payable for the three months ended February 28, 2026 and February 28, 2025 was as follows:


	For the three months ended		For the three months ended
	February 28, 2026		February 28, 2025
Interest expense on notes payable - Susser	$	183,416	$	223,001
Debt issuance costs - Susser		5,136		5,246
Total interest expense	$	188,552	$	228,247